Video | Promoted content 31-05-2024
Ahead of the European Elections in June 2024, EHPM calls on the EU to recognise food supplements as important allies for European citizens’ health, and to promote policies that empower consumers, and enable the continued growth of the European food supplement sector in the next mandate.
News 31-05-2024
On World No Tobacco Day (31 May), several non-governmental organisations (NGOs) have joined to call for a swift EU action on tobacco control.
News 30-05-2024
To mark the European Week Against Cancer, Euractiv met with Professor Jean-Yves Blay, Director of Public Policy for the European Society for Medical Oncology (ESMO) to assess what has been achieved to date and what is still on the ‘to do’ list for combating cancer.
News | Advocacy Lab Content 29-05-2024
Belgium and the Netherlands are pushing for a need-driven research model prioritising society's requirements, with an emphasis on addressing unmet medical needs, Belgium is viewed as setting the stage for future presidencies.
Bulgaria’s updated position paper on the revision of the EU's pharmaceutical legislation underlines the importance of national competence and focuses on access to new medicines for citizens of poorer countries.
News 29-05-2024
It’s the European Week Against Cancer (EWAC) and Euractiv is taking the opportunity to highlight the issue of rare cancers in this week’s Health Brief.
Special Report | News 29-05-2024
Much has been achieved, as summarised in the recent communication on the European Health Union. However, two major areas will spill over onto the desks of the next Parliament: the pharma package and health determinants.
News | Advocacy Lab Content 28-05-2024
Hungarian President Tamás Sulyok is considering legalising euthanasia in Hungary by granting pardons to people assisting in the death of incurable patients.
The Czech Health Ministry has circulated a draft law to urgently reform the salaries of healthcare workers and doctors, in a move to address long-standing remuneration issues and doctors' protests.
Poland's vaccination finance decision-making process is being scrutinised by a specialised team of experts, comparing their methodology to European standards and identifying areas for improvement.
The pipeline of new antibiotics to curb the antimicrobial resistance crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives.
Antimicrobial resistance is on the rise, prompting the Swedish government to invite the European Centre for Disease Prevention and Control and the European Commission to review Sweden’s AMR strategy.
The Dutch innovative medicines association, VIG, says amendments to the pharmaceutical legislation adopted by the European Parliament aren't enough to ease concerns.
News 27-05-2024
Despite an additional week of intensive talks, negotiators were unable to reach agreement on the text of a new Pandemic Accord ahead of the World Health Assembly.
News 23-05-2024
“What kind of europe do we want? A Europe that puts patients’ needs at the forefront, or that prioritises the interests of big pharma?” says Greens health expert Tilly Metz
‘The European Health Union: Acting together for people’s health’ is how the Commission summed up its last five years of actions in health. The EU went "from firefighter to architect", in the words of Commission Vice President Margaritis Schinas, but not everyone is convinced the current architecture is optimal.
Opinion | Promoted content 22-05-2024
Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of innovation.
News 22-05-2024
The European Commission will present its update of the ‘European Health Union: a Europe that prepares, prevents and protects' on Wednesday (22 May). Like the Belgian motto, ‘L’Union fait la force’ [Unity makes strength], the Health Union's aim is to create a more resilient Europe.
News | Advocacy Lab Content 21-05-2024
Polish medical innovation has seen improvements, yet significant challenges remain, according to the latest Access GAP data, with access to innovative therapies and diagnostics increasing.
In Czechia, new data shows over 16,000 patients have been included in the research efforts for new drugs and vaccines, with clinical trials most frequently focusing on oncology and immunology.
Swedish doctors fear Swedish patients may have to pay out-of-pocket for a treatment that targets a genetic cause of the neurodegenerative disease ALS. European authorities will decide this spring whether the drug can be marketed in Europe.
The Bulgarian pharmaceutical industry fears that the country's political crisis could negatively impact the protection of national interests during the negotiations on the new European pharmaceutical legislation.
Special Report | News | Advocacy Lab Content 21-05-2024
Genetic diagnostic technology advances for rare diseases offer hope, but gene-tech comes wrapped in complex ethical concerns. Will Europe accelerate modern diagnostics, or will ethical concerns slow and limit innovation?
News 21-05-2024
An infected blood scandal in Britain was no accident but the fault of doctors and a succession of governments that led to 3,000 deaths and thousands more contracting hepatitis or HIV, a public inquiry reported on Monday (20 May).
